Trial intelligence / Profile preview

Treatment of Childhood Regressive Autism With Minocycline

NCT00409747Phase 4Completed

Sponsor
National Institute of Mental Health
Start
Nov 2006
Primary completion
Jun 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of minocycline in Autism Spectrum Disorder (ASD), sponsored by National Institute of Mental Health. Started Nov 2006; status: completed.

02

Drugs

minocycline
03

Conditions

Autism Spectrum Disorder (ASD)

Beyond the preview

Go deeper on NCT00409747.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00409747.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call